Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Sept 2024
USA
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral...
Asia Regulations, Drug Approvals, EMA, Europe Pharma, FDA, Global Health, Safety Updates, USA Drug Updates